Planet 13 Holdings (PLNH) Cash from Investing Activities (2021 - 2026)

Planet 13 Holdings' (PLNH) quarterly Cash from Investing Activities came in at $854829.0 in Q1 2026, up 131.76% year-on-year from $368837.5 in Q1 2025, and down 57.58% on a QoQ basis from $2.0 million in Q4 2025.

Planet 13 Holdings (PLNH) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has 6 years of Cash from Investing Activities data on file, last reported at $854829.0 in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 131.76% year-over-year to $854829.0 in Q1 2026; TTM through Mar 2026 was $6.1 million, a 271.91% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 166.82% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $854829.0, down from $2.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for PLNH reached as high as $5.5 million in Q3 2025 and fell as low as -$7.7 million in Q2 2022.
  • Historically, Cash from Investing Activities has averaged -$1.4 million across 5 years, with a median of -$2.4 million in 2023.
  • Across the five-year window, Cash from Investing Activities surged 1206.36% in 2024 and tumbled 154.63% in 2025, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$1.0 million in 2022, then sank by 128.71% to -$2.4 million in 2023, then declined by 8.44% to -$2.5 million in 2024, then surged by 179.05% to $2.0 million in 2025, then plunged by 57.58% to $854829.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $854829.0 in Q1 2026, $2.0 million in Q4 2025, and $5.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.55 Bn 87.69 Bn - -
2 Teva Pharmaceutical Industries 36.00 Bn 32.26 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.59 Bn 30.65 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.52 Bn 23.45 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.07 Bn 20.91 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.28 Bn 18.47 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.78 Bn 16.47 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -60.00 Mn
10 Planet 13 Holdings 39.32 Mn 23.06 Mn 9.41 Mn 854,829.00

Historic Data

Download Data
DateValue
Mar 31, 2026 854,829.00
Mar 31, 2026 854,829.00
Dec 31, 2025 2.01 Mn
Dec 31, 2025 2.01 Mn
Sep 30, 2025 5.48 Mn
Sep 30, 2025 5.48 Mn
Jun 30, 2025 -2.28 Mn
Jun 30, 2025 -2.28 Mn
Mar 31, 2025 -2.69 Mn
Mar 31, 2025 -2.69 Mn
Dec 31, 2024 -2.55 Mn
Dec 31, 2024 -2.55 Mn
Sep 30, 2024 -2.46 Mn
Sep 30, 2024 -2.46 Mn
Jun 30, 2024 4.17 Mn
Jun 30, 2024 4.17 Mn
Mar 31, 2024 -2.94 Mn
Mar 31, 2024 -2.94 Mn
Dec 31, 2023 -2.35 Mn
Dec 31, 2023 -2.35 Mn